Woman and Man
- | Country :
- Serbia
- Switzerland
- Japan
- The 5 others...
- | organs : -
- | Specialty : -
Extract
This open-label extension study will allow subjects who have completed either the 3242K1-2000-WW or 3242K1-2001-JA study to receive up to an additional 48 weeks of ATN-103 treatment and will provide data on the long-term safety and tolerability of ATN-103 in subjects with rheumatoid arthritis.
Inclusion criteria
- Rheumatoid Arthritis